Medical Care
Global Cancer Screening Technology Market Research Report 2025
- Jul 08, 25
- ID: 348355
- Pages: 83
- Figures: 84
- Views: 34
The global market for Cancer Screening Technology was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Screening Technology in Lung Cancer Screening is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Screening Technology include Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Technology.
The Cancer Screening Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Screening Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BD
Siemens Healthineers
GE Healthcare
F. Hoffmann-La Roche
Olympus Corporation
FUJIFILM Corporation
Agilent Technologies
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Segment by Type
Instrument-based Inspection
Platform-based Inspection
Segment by Application
Lung Cancer Screening
Breast Cancer Screening
Prostate Cancer Screening
Colorectal Cancer Screening
Blood Cancer Screening
Liver Cancer Screening
Pancreatic Cancer Screening
Skin Cancer Screening
Cervical Cancer Screening
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
North American market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Cancer Screening Technology is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Cancer Screening Technology in Lung Cancer Screening is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Cancer Screening Technology include Abbott, BD, Siemens Healthineers, GE Healthcare, F. Hoffmann-La Roche, Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Eiken Chemical, Hitachi Chemical (Kyowa Medex), etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cancer Screening Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cancer Screening Technology.
The Cancer Screening Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cancer Screening Technology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cancer Screening Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BD
Siemens Healthineers
GE Healthcare
F. Hoffmann-La Roche
Olympus Corporation
FUJIFILM Corporation
Agilent Technologies
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
Segment by Type
Instrument-based Inspection
Platform-based Inspection
Segment by Application
Lung Cancer Screening
Breast Cancer Screening
Prostate Cancer Screening
Colorectal Cancer Screening
Blood Cancer Screening
Liver Cancer Screening
Pancreatic Cancer Screening
Skin Cancer Screening
Cervical Cancer Screening
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cancer Screening Technology company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument-based Inspection
1.2.3 Platform-based Inspection
1.3 Market by Application
1.3.1 Global Cancer Screening Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer Screening
1.3.3 Breast Cancer Screening
1.3.4 Prostate Cancer Screening
1.3.5 Colorectal Cancer Screening
1.3.6 Blood Cancer Screening
1.3.7 Liver Cancer Screening
1.3.8 Pancreatic Cancer Screening
1.3.9 Skin Cancer Screening
1.3.10 Cervical Cancer Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Technology Market Perspective (2020-2031)
2.2 Global Cancer Screening Technology Growth Trends by Region
2.2.1 Global Cancer Screening Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Screening Technology Historic Market Size by Region (2020-2025)
2.2.3 Cancer Screening Technology Forecasted Market Size by Region (2026-2031)
2.3 Cancer Screening Technology Market Dynamics
2.3.1 Cancer Screening Technology Industry Trends
2.3.2 Cancer Screening Technology Market Drivers
2.3.3 Cancer Screening Technology Market Challenges
2.3.4 Cancer Screening Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Technology Players by Revenue
3.1.1 Global Top Cancer Screening Technology Players by Revenue (2020-2025)
3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Screening Technology Revenue
3.4 Global Cancer Screening Technology Market Concentration Ratio
3.4.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2024
3.5 Global Key Players of Cancer Screening Technology Head office and Area Served
3.6 Global Key Players of Cancer Screening Technology, Product and Application
3.7 Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Technology Breakdown Data by Type
4.1 Global Cancer Screening Technology Historic Market Size by Type (2020-2025)
4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031)
5 Cancer Screening Technology Breakdown Data by Application
5.1 Global Cancer Screening Technology Historic Market Size by Application (2020-2025)
5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Screening Technology Market Size (2020-2031)
6.2 North America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Screening Technology Market Size by Country (2020-2025)
6.4 North America Cancer Screening Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Technology Market Size (2020-2031)
7.2 Europe Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Screening Technology Market Size by Country (2020-2025)
7.4 Europe Cancer Screening Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Technology Market Size (2020-2031)
8.2 Asia-Pacific Cancer Screening Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Technology Market Size (2020-2031)
9.2 Latin America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Screening Technology Market Size by Country (2020-2025)
9.4 Latin America Cancer Screening Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Technology Market Size (2020-2031)
10.2 Middle East & Africa Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cancer Screening Technology Introduction
11.1.4 Abbott Revenue in Cancer Screening Technology Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Cancer Screening Technology Introduction
11.2.4 BD Revenue in Cancer Screening Technology Business (2020-2025)
11.2.5 BD Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Cancer Screening Technology Introduction
11.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cancer Screening Technology Introduction
11.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025)
11.4.5 GE Healthcare Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Olympus Corporation
11.6.1 Olympus Corporation Company Details
11.6.2 Olympus Corporation Business Overview
11.6.3 Olympus Corporation Cancer Screening Technology Introduction
11.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.6.5 Olympus Corporation Recent Development
11.7 FUJIFILM Corporation
11.7.1 FUJIFILM Corporation Company Details
11.7.2 FUJIFILM Corporation Business Overview
11.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
11.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.7.5 FUJIFILM Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Screening Technology Introduction
11.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Cancer Screening Technology Introduction
11.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025)
11.9.5 Eiken Chemical Recent Development
11.10 Hitachi Chemical (Kyowa Medex)
11.10.1 Hitachi Chemical (Kyowa Medex) Company Details
11.10.2 Hitachi Chemical (Kyowa Medex) Business Overview
11.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
11.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025)
11.10.5 Hitachi Chemical (Kyowa Medex) Recent Development
11.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
11.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
11.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
11.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025)
11.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Cancer Screening Technology Introduction
11.12.4 Sysmex Revenue in Cancer Screening Technology Business (2020-2025)
11.12.5 Sysmex Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Technology Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Technology Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025)
11.14.5 R-Biopharm Recent Development
11.15 Immunostics
11.15.1 Immunostics Company Details
11.15.2 Immunostics Business Overview
11.15.3 Immunostics Cancer Screening Technology Introduction
11.15.4 Immunostics Revenue in Cancer Screening Technology Business (2020-2025)
11.15.5 Immunostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Instrument-based Inspection
1.2.3 Platform-based Inspection
1.3 Market by Application
1.3.1 Global Cancer Screening Technology Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Lung Cancer Screening
1.3.3 Breast Cancer Screening
1.3.4 Prostate Cancer Screening
1.3.5 Colorectal Cancer Screening
1.3.6 Blood Cancer Screening
1.3.7 Liver Cancer Screening
1.3.8 Pancreatic Cancer Screening
1.3.9 Skin Cancer Screening
1.3.10 Cervical Cancer Screening
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Screening Technology Market Perspective (2020-2031)
2.2 Global Cancer Screening Technology Growth Trends by Region
2.2.1 Global Cancer Screening Technology Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cancer Screening Technology Historic Market Size by Region (2020-2025)
2.2.3 Cancer Screening Technology Forecasted Market Size by Region (2026-2031)
2.3 Cancer Screening Technology Market Dynamics
2.3.1 Cancer Screening Technology Industry Trends
2.3.2 Cancer Screening Technology Market Drivers
2.3.3 Cancer Screening Technology Market Challenges
2.3.4 Cancer Screening Technology Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Screening Technology Players by Revenue
3.1.1 Global Top Cancer Screening Technology Players by Revenue (2020-2025)
3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2020-2025)
3.2 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cancer Screening Technology Revenue
3.4 Global Cancer Screening Technology Market Concentration Ratio
3.4.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2024
3.5 Global Key Players of Cancer Screening Technology Head office and Area Served
3.6 Global Key Players of Cancer Screening Technology, Product and Application
3.7 Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Screening Technology Breakdown Data by Type
4.1 Global Cancer Screening Technology Historic Market Size by Type (2020-2025)
4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031)
5 Cancer Screening Technology Breakdown Data by Application
5.1 Global Cancer Screening Technology Historic Market Size by Application (2020-2025)
5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cancer Screening Technology Market Size (2020-2031)
6.2 North America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cancer Screening Technology Market Size by Country (2020-2025)
6.4 North America Cancer Screening Technology Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cancer Screening Technology Market Size (2020-2031)
7.2 Europe Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cancer Screening Technology Market Size by Country (2020-2025)
7.4 Europe Cancer Screening Technology Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cancer Screening Technology Market Size (2020-2031)
8.2 Asia-Pacific Cancer Screening Technology Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025)
8.4 Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cancer Screening Technology Market Size (2020-2031)
9.2 Latin America Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cancer Screening Technology Market Size by Country (2020-2025)
9.4 Latin America Cancer Screening Technology Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Screening Technology Market Size (2020-2031)
10.2 Middle East & Africa Cancer Screening Technology Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025)
10.4 Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Cancer Screening Technology Introduction
11.1.4 Abbott Revenue in Cancer Screening Technology Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BD
11.2.1 BD Company Details
11.2.2 BD Business Overview
11.2.3 BD Cancer Screening Technology Introduction
11.2.4 BD Revenue in Cancer Screening Technology Business (2020-2025)
11.2.5 BD Recent Development
11.3 Siemens Healthineers
11.3.1 Siemens Healthineers Company Details
11.3.2 Siemens Healthineers Business Overview
11.3.3 Siemens Healthineers Cancer Screening Technology Introduction
11.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025)
11.3.5 Siemens Healthineers Recent Development
11.4 GE Healthcare
11.4.1 GE Healthcare Company Details
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare Cancer Screening Technology Introduction
11.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025)
11.4.5 GE Healthcare Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Olympus Corporation
11.6.1 Olympus Corporation Company Details
11.6.2 Olympus Corporation Business Overview
11.6.3 Olympus Corporation Cancer Screening Technology Introduction
11.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.6.5 Olympus Corporation Recent Development
11.7 FUJIFILM Corporation
11.7.1 FUJIFILM Corporation Company Details
11.7.2 FUJIFILM Corporation Business Overview
11.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
11.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025)
11.7.5 FUJIFILM Corporation Recent Development
11.8 Agilent Technologies
11.8.1 Agilent Technologies Company Details
11.8.2 Agilent Technologies Business Overview
11.8.3 Agilent Technologies Cancer Screening Technology Introduction
11.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025)
11.8.5 Agilent Technologies Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Cancer Screening Technology Introduction
11.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025)
11.9.5 Eiken Chemical Recent Development
11.10 Hitachi Chemical (Kyowa Medex)
11.10.1 Hitachi Chemical (Kyowa Medex) Company Details
11.10.2 Hitachi Chemical (Kyowa Medex) Business Overview
11.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
11.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025)
11.10.5 Hitachi Chemical (Kyowa Medex) Recent Development
11.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
11.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
11.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
11.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
11.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025)
11.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
11.12 Sysmex
11.12.1 Sysmex Company Details
11.12.2 Sysmex Business Overview
11.12.3 Sysmex Cancer Screening Technology Introduction
11.12.4 Sysmex Revenue in Cancer Screening Technology Business (2020-2025)
11.12.5 Sysmex Recent Development
11.13 QIAGEN
11.13.1 QIAGEN Company Details
11.13.2 QIAGEN Business Overview
11.13.3 QIAGEN Cancer Screening Technology Introduction
11.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2020-2025)
11.13.5 QIAGEN Recent Development
11.14 R-Biopharm
11.14.1 R-Biopharm Company Details
11.14.2 R-Biopharm Business Overview
11.14.3 R-Biopharm Cancer Screening Technology Introduction
11.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025)
11.14.5 R-Biopharm Recent Development
11.15 Immunostics
11.15.1 Immunostics Company Details
11.15.2 Immunostics Business Overview
11.15.3 Immunostics Cancer Screening Technology Introduction
11.15.4 Immunostics Revenue in Cancer Screening Technology Business (2020-2025)
11.15.5 Immunostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cancer Screening Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instrument-based Inspection
Table 3. Key Players of Platform-based Inspection
Table 4. Global Cancer Screening Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Screening Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Screening Technology Market Share by Region (2020-2025)
Table 8. Global Cancer Screening Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Screening Technology Market Share by Region (2026-2031)
Table 10. Cancer Screening Technology Market Trends
Table 11. Cancer Screening Technology Market Drivers
Table 12. Cancer Screening Technology Market Challenges
Table 13. Cancer Screening Technology Market Restraints
Table 14. Global Cancer Screening Technology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Screening Technology Market Share by Players (2020-2025)
Table 16. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
Table 17. Ranking of Global Top Cancer Screening Technology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Screening Technology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Screening Technology, Headquarters and Area Served
Table 20. Global Key Players of Cancer Screening Technology, Product and Application
Table 21. Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Screening Technology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Screening Technology Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Screening Technology Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Screening Technology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Screening Technology Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Screening Technology Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Screening Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Company Details
Table 47. Abbott Business Overview
Table 48. Abbott Cancer Screening Technology Product
Table 49. Abbott Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Cancer Screening Technology Product
Table 54. BD Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. Siemens Healthineers Company Details
Table 57. Siemens Healthineers Business Overview
Table 58. Siemens Healthineers Cancer Screening Technology Product
Table 59. Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers Recent Development
Table 61. GE Healthcare Company Details
Table 62. GE Healthcare Business Overview
Table 63. GE Healthcare Cancer Screening Technology Product
Table 64. GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 65. GE Healthcare Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Cancer Screening Technology Product
Table 69. F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Olympus Corporation Company Details
Table 72. Olympus Corporation Business Overview
Table 73. Olympus Corporation Cancer Screening Technology Product
Table 74. Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 75. Olympus Corporation Recent Development
Table 76. FUJIFILM Corporation Company Details
Table 77. FUJIFILM Corporation Business Overview
Table 78. FUJIFILM Corporation Cancer Screening Technology Product
Table 79. FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 80. FUJIFILM Corporation Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Cancer Screening Technology Product
Table 84. Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Eiken Chemical Company Details
Table 87. Eiken Chemical Business Overview
Table 88. Eiken Chemical Cancer Screening Technology Product
Table 89. Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 90. Eiken Chemical Recent Development
Table 91. Hitachi Chemical (Kyowa Medex) Company Details
Table 92. Hitachi Chemical (Kyowa Medex) Business Overview
Table 93. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Product
Table 94. Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 95. Hitachi Chemical (Kyowa Medex) Recent Development
Table 96. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 97. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 98. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Product
Table 99. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 100. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
Table 101. Sysmex Company Details
Table 102. Sysmex Business Overview
Table 103. Sysmex Cancer Screening Technology Product
Table 104. Sysmex Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 105. Sysmex Recent Development
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Cancer Screening Technology Product
Table 109. QIAGEN Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. R-Biopharm Company Details
Table 112. R-Biopharm Business Overview
Table 113. R-Biopharm Cancer Screening Technology Product
Table 114. R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 115. R-Biopharm Recent Development
Table 116. Immunostics Company Details
Table 117. Immunostics Business Overview
Table 118. Immunostics Cancer Screening Technology Product
Table 119. Immunostics Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 120. Immunostics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cancer Screening Technology Picture
Figure 2. Global Cancer Screening Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Screening Technology Market Share by Type: 2024 VS 2031
Figure 4. Instrument-based Inspection Features
Figure 5. Platform-based Inspection Features
Figure 6. Global Cancer Screening Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Screening Technology Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Screening Case Studies
Figure 9. Breast Cancer Screening Case Studies
Figure 10. Prostate Cancer Screening Case Studies
Figure 11. Colorectal Cancer Screening Case Studies
Figure 12. Blood Cancer Screening Case Studies
Figure 13. Liver Cancer Screening Case Studies
Figure 14. Pancreatic Cancer Screening Case Studies
Figure 15. Skin Cancer Screening Case Studies
Figure 16. Cervical Cancer Screening Case Studies
Figure 17. Cancer Screening Technology Report Years Considered
Figure 18. Global Cancer Screening Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Cancer Screening Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Cancer Screening Technology Market Share by Region: 2024 VS 2031
Figure 21. Global Cancer Screening Technology Market Share by Players in 2024
Figure 22. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Cancer Screening Technology Revenue in 2024
Figure 24. North America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Cancer Screening Technology Market Share by Country (2020-2031)
Figure 26. United States Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Cancer Screening Technology Market Share by Country (2020-2031)
Figure 30. Germany Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Cancer Screening Technology Market Share by Region (2020-2031)
Figure 38. China Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Cancer Screening Technology Market Share by Country (2020-2031)
Figure 46. Mexico Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Cancer Screening Technology Market Share by Country (2020-2031)
Figure 50. Turkey Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 54. BD Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 55. Siemens Healthineers Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 56. GE Healthcare Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 58. Olympus Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 59. FUJIFILM Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 60. Agilent Technologies Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 61. Eiken Chemical Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 62. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 63. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 64. Sysmex Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 65. QIAGEN Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 66. R-Biopharm Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 67. Immunostics Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Table 1. Global Cancer Screening Technology Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Instrument-based Inspection
Table 3. Key Players of Platform-based Inspection
Table 4. Global Cancer Screening Technology Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Cancer Screening Technology Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Cancer Screening Technology Market Share by Region (2020-2025)
Table 8. Global Cancer Screening Technology Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Cancer Screening Technology Market Share by Region (2026-2031)
Table 10. Cancer Screening Technology Market Trends
Table 11. Cancer Screening Technology Market Drivers
Table 12. Cancer Screening Technology Market Challenges
Table 13. Cancer Screening Technology Market Restraints
Table 14. Global Cancer Screening Technology Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Cancer Screening Technology Market Share by Players (2020-2025)
Table 16. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
Table 17. Ranking of Global Top Cancer Screening Technology Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Cancer Screening Technology Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Cancer Screening Technology, Headquarters and Area Served
Table 20. Global Key Players of Cancer Screening Technology, Product and Application
Table 21. Global Key Players of Cancer Screening Technology, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Cancer Screening Technology Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Cancer Screening Technology Revenue Market Share by Type (2020-2025)
Table 25. Global Cancer Screening Technology Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Cancer Screening Technology Revenue Market Share by Type (2026-2031)
Table 27. Global Cancer Screening Technology Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Cancer Screening Technology Revenue Market Share by Application (2020-2025)
Table 29. Global Cancer Screening Technology Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Cancer Screening Technology Revenue Market Share by Application (2026-2031)
Table 31. North America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Cancer Screening Technology Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Cancer Screening Technology Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Cancer Screening Technology Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Cancer Screening Technology Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Cancer Screening Technology Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Cancer Screening Technology Market Size by Country (2026-2031) & (US$ Million)
Table 46. Abbott Company Details
Table 47. Abbott Business Overview
Table 48. Abbott Cancer Screening Technology Product
Table 49. Abbott Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 50. Abbott Recent Development
Table 51. BD Company Details
Table 52. BD Business Overview
Table 53. BD Cancer Screening Technology Product
Table 54. BD Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 55. BD Recent Development
Table 56. Siemens Healthineers Company Details
Table 57. Siemens Healthineers Business Overview
Table 58. Siemens Healthineers Cancer Screening Technology Product
Table 59. Siemens Healthineers Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 60. Siemens Healthineers Recent Development
Table 61. GE Healthcare Company Details
Table 62. GE Healthcare Business Overview
Table 63. GE Healthcare Cancer Screening Technology Product
Table 64. GE Healthcare Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 65. GE Healthcare Recent Development
Table 66. F. Hoffmann-La Roche Company Details
Table 67. F. Hoffmann-La Roche Business Overview
Table 68. F. Hoffmann-La Roche Cancer Screening Technology Product
Table 69. F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 70. F. Hoffmann-La Roche Recent Development
Table 71. Olympus Corporation Company Details
Table 72. Olympus Corporation Business Overview
Table 73. Olympus Corporation Cancer Screening Technology Product
Table 74. Olympus Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 75. Olympus Corporation Recent Development
Table 76. FUJIFILM Corporation Company Details
Table 77. FUJIFILM Corporation Business Overview
Table 78. FUJIFILM Corporation Cancer Screening Technology Product
Table 79. FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 80. FUJIFILM Corporation Recent Development
Table 81. Agilent Technologies Company Details
Table 82. Agilent Technologies Business Overview
Table 83. Agilent Technologies Cancer Screening Technology Product
Table 84. Agilent Technologies Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 85. Agilent Technologies Recent Development
Table 86. Eiken Chemical Company Details
Table 87. Eiken Chemical Business Overview
Table 88. Eiken Chemical Cancer Screening Technology Product
Table 89. Eiken Chemical Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 90. Eiken Chemical Recent Development
Table 91. Hitachi Chemical (Kyowa Medex) Company Details
Table 92. Hitachi Chemical (Kyowa Medex) Business Overview
Table 93. Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Product
Table 94. Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 95. Hitachi Chemical (Kyowa Medex) Recent Development
Table 96. Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
Table 97. Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
Table 98. Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Product
Table 99. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 100. Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development
Table 101. Sysmex Company Details
Table 102. Sysmex Business Overview
Table 103. Sysmex Cancer Screening Technology Product
Table 104. Sysmex Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 105. Sysmex Recent Development
Table 106. QIAGEN Company Details
Table 107. QIAGEN Business Overview
Table 108. QIAGEN Cancer Screening Technology Product
Table 109. QIAGEN Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 110. QIAGEN Recent Development
Table 111. R-Biopharm Company Details
Table 112. R-Biopharm Business Overview
Table 113. R-Biopharm Cancer Screening Technology Product
Table 114. R-Biopharm Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 115. R-Biopharm Recent Development
Table 116. Immunostics Company Details
Table 117. Immunostics Business Overview
Table 118. Immunostics Cancer Screening Technology Product
Table 119. Immunostics Revenue in Cancer Screening Technology Business (2020-2025) & (US$ Million)
Table 120. Immunostics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
Table 124. Authors List of This Report
List of Figures
Figure 1. Cancer Screening Technology Picture
Figure 2. Global Cancer Screening Technology Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cancer Screening Technology Market Share by Type: 2024 VS 2031
Figure 4. Instrument-based Inspection Features
Figure 5. Platform-based Inspection Features
Figure 6. Global Cancer Screening Technology Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Cancer Screening Technology Market Share by Application: 2024 VS 2031
Figure 8. Lung Cancer Screening Case Studies
Figure 9. Breast Cancer Screening Case Studies
Figure 10. Prostate Cancer Screening Case Studies
Figure 11. Colorectal Cancer Screening Case Studies
Figure 12. Blood Cancer Screening Case Studies
Figure 13. Liver Cancer Screening Case Studies
Figure 14. Pancreatic Cancer Screening Case Studies
Figure 15. Skin Cancer Screening Case Studies
Figure 16. Cervical Cancer Screening Case Studies
Figure 17. Cancer Screening Technology Report Years Considered
Figure 18. Global Cancer Screening Technology Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 19. Global Cancer Screening Technology Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 20. Global Cancer Screening Technology Market Share by Region: 2024 VS 2031
Figure 21. Global Cancer Screening Technology Market Share by Players in 2024
Figure 22. Global Top Cancer Screening Technology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Screening Technology as of 2024)
Figure 23. The Top 10 and 5 Players Market Share by Cancer Screening Technology Revenue in 2024
Figure 24. North America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. North America Cancer Screening Technology Market Share by Country (2020-2031)
Figure 26. United States Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Canada Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Cancer Screening Technology Market Share by Country (2020-2031)
Figure 30. Germany Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. France Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. U.K. Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Italy Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Russia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Nordic Countries Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Cancer Screening Technology Market Share by Region (2020-2031)
Figure 38. China Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Japan Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. South Korea Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. India Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Australia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Cancer Screening Technology Market Share by Country (2020-2031)
Figure 46. Mexico Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Brazil Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Cancer Screening Technology Market Share by Country (2020-2031)
Figure 50. Turkey Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. UAE Cancer Screening Technology Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. Abbott Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 54. BD Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 55. Siemens Healthineers Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 56. GE Healthcare Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 58. Olympus Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 59. FUJIFILM Corporation Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 60. Agilent Technologies Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 61. Eiken Chemical Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 62. Hitachi Chemical (Kyowa Medex) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 63. Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 64. Sysmex Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 65. QIAGEN Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 66. R-Biopharm Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 67. Immunostics Revenue Growth Rate in Cancer Screening Technology Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232